Terms of Service
Welcome to Medical Imaging for Cancer Diagnosis, a comprehensive online resource dedicated to advancing knowledge about medical imaging in cancer diagnosis. By accessing or using our website, you agree to comply with the following terms and conditions.
User Conduct Guidelines
-
Content Ownership: You must respect intellectual property rights and copyright laws. Our site’s content, including text, images, videos, and graphics, is protected by copyright. You are prohibited from reproducing, distributing, or stealing any part of our content without explicit permission from the owners.
-
Spamming: Spamming activities are not tolerated on our platform. This includes excessive messaging, unsolicited advertising, or any form of commercial promotion that disrupts our community.
-
Illegal Activities: Our website is intended for educational and informational purposes only. You may not use it to engage in or promote any illegal activities, including but not limited to, sharing sensitive medical advice, distributing restricted materials, or engaging in cybercrime.
User Account Termination
We reserve the right to terminate or suspend access to our website for any user who violates these terms and conditions. This includes, but is not limited to, accounts found to be involved in spamming activities, copyright infringement, or engaging in illegal conduct.
Intellectual Property
Medical Imaging for Cancer Diagnosis owns all intellectual property rights related to the website, including its content, design, and underlying technology. Trademarks and registered marks are the property of their respective owners.
Limitation of Liability
While we strive to provide accurate and up-to-date information, no warranty is given in relation to the accuracy or completeness of the content on this website. We will not be liable for any loss or damage arising from your use of the site, including but not limited to, indirect, incidental, special, or consequential damages.
Effective Date
These Terms of Service shall come into effect on March 18, 2024, and remain in force unless updated or amended by our team.
For any inquiries or concerns regarding these terms, please contact us at: [email protected].